早发型脓毒症评估中C反应蛋白使用趋势及其与抗生素使用的关联
该回顾性队列研究分析了2009至2021年美国572个新生儿重症监护病房(NICU)中早发型脓毒症(EOS)评估时C反应蛋白(CRP)的使用情况。研究发现,高CRP使用NICU比例从24.7%降至17.4%,低CRP使用NICU比例从47.9%升至64.8%;高CRP使用与抗生素疗程超过3天相关(调整风险比1.95,95%CI 1.54-2.48),但与死亡率无显著差异。
要点
- 高CRP使用NICU比例从2009年24.7%降至2021年17.4%,低使用比例从47.9%升至64.8%。
- 高CRP使用与死亡率≤7天无显著差异(调整风险差-0.02%,95%CI -0.04%至0.0008%)。
核心结论
- 在EOS评估中高CRP使用的NICU与更长的抗生素疗程相关,但与死亡率≤7天无关。
- 减少EOS评估中常规CRP使用可能是新生儿抗生素管理的一个目标。
研究设计与样本
- 回顾性队列研究,纳入2009至2021年向Premier Healthcare Database贡献数据的572个美国NICU。
- EOS评估定义为出生后≤3天进行血培养计费。
- CRP使用定义为EOS评估婴儿中出生后≤3天进行CRP检测的比例,分为低(<25%)、中低(25至<50%)、中高(50至<75%)、高(≥75%)四类。
主要发现
- 多变量调整回归分析显示,高CRP使用与抗生素疗程超过3天的调整风险比为1.95(95%CI 1.54,2.48)。
- 高使用NICU的死亡率风险无差异(调整风险差-0.02%,95%CI -0.04%,0.0008%)。
关键数值与推荐
- CRP使用分类阈值:低<25%;中低25至<50%;中高50至<75%;高≥75%。
- EOS评估定义:出生后≤3天血培养计费。
- 结局指标:出生后≤7天抗生素使用和死亡率。
临床怎么用
- 临床可考虑减少EOS评估中常规CRP检测,以缩短抗生素疗程。
- 高CRP使用NICU应关注抗生素管理,避免不必要的 prolonged 抗生素治疗。
局限性
- 回顾性队列研究设计可能引入残余混杂。
- 数据来源于Premier Healthcare Database,可能不全面代表所有NICU。
- CRP使用分类基于NICU水平比例,未评估个体患者层面因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the prevalence of C-reactive protein (CRP) use in early-onset sepsis (EOS) evaluations in neonatal intensive care units (NICUs) across the US over time and to determine the association between CRP use and antibiotic use. STUDY DESIGN: A retrospective cohort study of NICUs contributing data to Premier Healthcare Database from 2009 through 2021. EOS evaluation was defined as a blood culture charge ≤ 3 days after birth. CRP use for each NICU was calculated as the proportion of infants with a CRP test obtained ≤ 3 days after birth among those undergoing an EOS evaluation and categorized as, low (<25%); medium-low (25 to < 50%), medium-high (50 to < 75%), and high (≥75%). Outcomes included antibiotic use and mortality ≤ 7 days after birth. RESULTS: Among 572 NICUs, CRP use varied widely and was associated with time. The proportion of NICUs with high CRP use decreased from 2009 to 2021 (24.7% vs 17.4%, P < .001), and those with low CRP use increased (47.9% vs 64.8%, P < .001). Compared with low-use NICUs, high-use NICUs more frequently continued antibiotics > 3 days (10% vs 25%, P < .001). This association persisted in multivariable-adjusted regression analyses (adjusted risk ratio 1.95, 95%CI 1.54, 2.48). Risk of mortality was not different in high-use NICUs (adjusted risk difference -0.02%, 95%CI -0.04%, 0.0008%). CONCLUSIONS: CRP use in EOS evaluations varied widely across NICUs. High CRP use was associated with prolonged antibiotic therapy but not mortality ≤ 7 days after birth. Reducing routine CRP use in EOS evaluations may be a target for neonatal antibiotic stewardship efforts.
引用
- Barboza AZ, Flannery DD, Shu D, et al. Trends in C-Reactive Protein Use in Early-onset Sepsis Evaluations and Associated Antibiotic Use. J Pediatr. 2024. PMID: 38901777. doi:10.1016/j.jpeds.2024.114153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。